OVERVIEW
Amid the global esoteric testing market size is expected to hit USD 41.3 billion by 2026, growing over the forecast period at a CAGR of 10.03%. Increasing demand for early and reliable diagnosis of disease, growing infectious disease prevalence, increasing public-private investment as well as research funding & grants to improve advanced laboratory testing methods, and developments in medical diagnostic techniques are key drivers of market growth. The report will also account for COVID-19 as a key market contributor.TABLE OF CONTENT
- 1.1 Study Objectives
- 1.2 Market Definition
- 1.3 Study Scope
- 1.3.1 Markets Covered
- 1.3.2 Geographic Scope
- 2 RESEARCH METHODOLOGY
- 2.1 Research Data
- 2.1.1 Secondary Data
- 2.1.1.1 Key Data From Secondary Sources
- 2.1.2 Primary Data
- 2.1.2.1 Key Data From Primary Sources
- 2.1.2.2 Key Industry Insights
- 2.1.2.3 Breakdown of Primaries
- 2.1.1 Secondary Data
- 2.2 Market Size Estimation
- 2.2.1 Bottom-Up Approach
- 2.2.2 Top-Down Approach
- 2.3 Market Breakdown and Data Triangulation
- 2.4 Research Assumptions
- 2.1 Research Data
- 3 Global Esoteric Testing Market – Executive Summary
- 3.1 Market Revenue, Market Size and Key Trends by Company
- 3.2 Key Trends by type of Application
- 3.3 Key Trends segmented by Geography
- 4 Global Esoteric Testing Market – Comparative Analysis
- 4.1 Product Benchmarking - Top 10 companies
- 4.2 Top 5 Financials Analysis
- 4.3 Market Value split by Top 10 companies
- 4.4 Patent Analysis - Top 10 companies
- 4.5 Pricing Analysis
- 5 Global Esoteric Testing Market – Industry Market Entry Scenario
- 5.1 Regulatory Framework Overview
- 5.2 New Business and Ease of Doing business index
- 5.3 Case studies of successful ventures
- 5.4 Customer Analysis – Top 10 companies
- 6 Global Esoteric Testing Market - Market Forces
- 6.1 Introduction
- 6.2 Market Dynamics
- 6.2.1 Drivers
- 6.2.2 Opportunities
- 6.2.3 Challenges
- 6.3 Porters Analysis of Market
- 6.3.1 Bargaining power of suppliers
- 6.3.2 Bargaining powers of customers
- 6.3.3 Threat of new entrants
- 6.3.4 Rivalry among existing players
- 6.3.5 Threat of substitutes
- 7 Global Esoteric Testing Market - Strategic Analysis
- 7.1 Value Chain analysis
- 7.2 Product Life Cycle
- 7.3 Supplier and distributor analysis (Market share and product dealing strategies)
- 8 Global Esoteric Testing Market – By Type (Market Size – & million/billion)
- 8.1 Infectious Diseases Testing
- 8.2 Neurology Testing
- 8.3 Endocrinology Testing
- 8.4 Oncology testing
- 8.5 Immunology Testing
- 8.6 Genetic Testing
- 8.7 Others
- 9 Global Esoteric Testing Market - By Technology
- 9.1 Chemiluminescence Immunoassay (CLIA)
- 9.2 Enzyme-linked Immunosorbent Assay (ELISA)
- 9.3 Mass Spectrometry
- 9.4 Real Time - PCR
- 9.5 Flow Cytometry
- 9.6 Radioimmunoassay
- 9.7 Others
- 10 Global Esoteric Testing Market - By Laboratory Type
- 10.1 Independent & Reference Laboratories
- 10.2 Hospital Laboratories
- 11 Global Esoteric Testing Market – By Geography (Market Size – & million/billion)
- 11.1 Introduction
- 11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 U.K
- 11.3.2 Germany
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia-Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Rest of APAC
- 11.5 Rest of the World
- 11.5.1 South America
- 11.5.2 Middle East
- 11.5.3 Africa
- 12 Global Esoteric Testing Market – Entropy
- 12.1 New product launches
- 12.2 M&A's, collaborations, JVs and partnerships
- 13 Global Esoteric Testing Market Company Profile (Key Players)
- 13.1 Market Share, Company Revenue, Products, M&A, Developments
- 13.2 Labcorp
- 13.3 Quest Diagnostics
- 13.4 Sonic Healthcare
- 13.5 Opko Health
- 13.6 Miraca Holdings
- 13.7 Foundation Medicine
- 13.8 ACM Global Laboratories
- 13.9 Myriad Genetics
- 13.10 Primary Health Care
- 13.11 Healthscope
- 13.12 Company 11 & more
- 14 Global Esoteric Testing Market - Appendix
- 14.1 Sources
- 14.2 Abbreviations
Esoteric Testing Market by Lab Type (Hospital Laboratories, Independent Labs), Type (Oncology, Infectious Disease, Endocrinology, Toxicology, Immunology, Neurology, Genetic Testing), Technology (CLIA, ELISA, Mass Spectrometry, PCR) – 2022 to 2027
Category: HealthcareSKU: GMS-1279
×